Cargando…
Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases
The search for effective drugs to treat new and existing diseases is a laborious one requiring a large investment of capital, resources, and time. The coronavirus 2019 (COVID-19) pandemic has been a painful reminder of the lack of development of new antimicrobial agents to treat emerging infectious...
Autores principales: | Bess, Adam, Berglind, Frej, Mukhopadhyay, Supratik, Brylinski, Michal, Griggs, Nicholas, Cho, Tiffany, Galliano, Chris, Wasan, Kishor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570449/ https://www.ncbi.nlm.nih.gov/pubmed/34748992 http://dx.doi.org/10.1016/j.drudis.2021.10.022 |
Ejemplares similares
-
Web resources facilitate drug discovery in treatment of COVID-19
por: Mei, Long-Can, et al.
Publicado: (2021) -
Applications of density functional theory in COVID-19 drug modeling
por: Ye, Naike, et al.
Publicado: (2022) -
Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein
por: Verma, Saroj, et al.
Publicado: (2022) -
Diagnostic testing laboratories are valuable partners for disease gene discovery: 5‐year experience with GeneMatcher
por: Towne, Meghan C., et al.
Publicado: (2022) -
Beacon v2 and Beacon networks: A “lingua franca” for federated data discovery in biomedical genomics, and beyond
por: Rambla, Jordi, et al.
Publicado: (2022)